1.Distinct Clinical Characteristics Depending on Cerebral Amyloid Positivity in Patients with Alzheimer Disease Dementia.
So Yeon JEON ; Min Soo BYUN ; Dahyun YI ; Jun Ho LEE ; Young Min CHOE ; Hyun Jung KIM ; Hyewon BAEK ; Jun Young LEE ; Dong Woo LEE ; Na Young HAN ; Seung Hoon LEE ; Kang KO ; Yu Kyeong KIM ; Yun Sang LEE ; Younghwa LEE ; Hyunwoong KO ; Kyoungjin CHU ; Dong Young LEE
Journal of Korean Geriatric Psychiatry 2016;20(2):68-74
OBJECTIVE: The present study investigated the clinical characteristics of Alzheimer's disease (AD) dementia with low brain amyloid-beta (Aβ-AD) burden comparing with AD dementia with high amyloid-beta burden (Aβ+AD). We also developed a prediction model for the amyloid positivity on ¹¹C-labelled Pittsburgh Compound B (PiB) positron emission tomography (PET) with distinct clinical variables in AD dementia patients. METHODS: Fifty-nine clinically defined AD dementia individuals, who participated in the Korean Brain Aging Study for Early diagnosis and prediction of AD (KBASE) study, were included. All the subjects received comprehensive clinical evaluations and PiB-PET. Based on cerebral PiB retention, all subjects were divided into Aβ+AD (n=47) and Aβ-AD (n=12) subgroups. To develop a prediction model for amyloid positivity, stepwise multiple logistic regression analysis was conducted. RESULTS: When compared to Aβ+AD, Aβ-AD showed older age, later age-at-onset, and lower education. In regard of risk factors for dementia, Aβ-AD had higher frequency of hypertension and diabetes mellitus as well as lower frequency of apolipoprotein E (APOE) ε4 allele. Although there was no between group difference in Clinical Dementia Rating (CDR) or CDR sum-of-boxes scores, mini-mental state examination and constructional recall scores were higher for Aβ-AD than Aβ+AD. The final amyloid positivity prediction model included APOE4 genotype, hypertension, and diabetes mellitus. CONCLUSION: The findings from this study indicated that clinically diagnosed AD dementia may have high possibility of not being pathological AD if they have older age and higher vascular risks, and did not have APOE4 genotype.
Age of Onset
;
Aging
;
Alleles
;
Alzheimer Disease*
;
Amyloid*
;
Apolipoprotein E4
;
Apolipoproteins
;
Brain
;
Dementia*
;
Diabetes Mellitus
;
Early Diagnosis
;
Education
;
Genotype
;
Humans
;
Hypertension
;
Logistic Models
;
Positron-Emission Tomography
;
Risk Factors
2.Intravenous fluid prescription practices among pediatric residents in Korea.
Jiwon M LEE ; Younghwa JUNG ; Se Eun LEE ; Jun Ho LEE ; Kee Hyuck KIM ; Ja Wook KOO ; Young Seo PARK ; Hae Il CHEONG ; Il Soo HA ; Yong CHOI ; Hee Gyung KANG
Korean Journal of Pediatrics 2013;56(7):282-285
PURPOSE: Recent studies have established the association between hypotonic fluids administration and hospital-acquired hyponatremia in children, and have contended that hypotonic fluids be removed from routine practice. To assess current intravenous fluid prescription practices among Korean pediatric residents and to call for updated clinical practice education. METHODS: A survey-based analysis was carried out. Pediatric residents at six university hospitals in Korea completed a survey consisting of four questions. Each question supposed a unique scenario in which the respondents were to prescribe either a hypotonic or an isotonic fluid for the patient. RESULTS: Ninety-one responses were collected and analyzed. In three of the four scenarios, a significant majority prescribed the hypotonic fluids (98.9%, 85.7%, and 69.2%, respectively). Notably, 69.2% of the respondents selected the hypotonic fluids for postoperative management. Almost all (96.7%) selected the isotonic fluids for hydration therapy. CONCLUSION: In the given scenarios, the majority of Korean pediatric residents would prescribe a hypotonic fluid, except for initial hydration. The current state of pediatric fluid management, notably, heightens the risk of hospital-acquired hyponatremia. Updated clinical practice education on intravenous fluid prescription, therefore, is urgently required.
Child
;
Surveys and Questionnaires
;
Fluid Therapy
;
Hospitals, University
;
Humans
;
Hyponatremia
;
Korea
;
Pediatrics
;
Prescriptions
3.Validation of the Korean Version of the Anosognosia Questionnaire for Dementia
Gi Hwan BYEON ; Woo Jin KIM ; Min Soo BYUN ; Jun Ho LEE ; So Yeon JEON ; Kang KO ; Kiyoung SUNG ; Dongkyun HAN ; Haejung JOUNG ; Younghwa LEE ; Gijung JUNG ; Han Na LEE ; Dahyun YI ; Dong Young LEE ;
Psychiatry Investigation 2021;18(4):324-331
Objective:
Anosognosia is a common phenomenon in individuals with dementia. Anosognosia Questionnaire for dementia (AQ-D) is a well-known scale for evaluating anosognosia. This study aimed to establish a Korean version of the AQ-D (AQ-D-K) and to evaluate the reliability and validity of the AQ-D-K in patients with Alzheimer’s disease (AD) dementia.
Methods:
We translated the original English version of AQ-D into Korean (AQ-D-K). Eighty-four subjects with very mild or mild AD dementia and their caregivers participated. Reliability of AQ-D-K was assessed by internal consistency and one-month test-retest reliability. Construct validity and concurrent validity were also evaluated.
Results:
Internal consistencies of the AQ-D-K patient form and caregiver form were high (Cronbach alpha 0.95 and 0.93, respectively). The test-retest reliability of AQ-D-K measured by intra-class correlation coefficient was 0.84. Three factors were identified: 1) anosognosia of instrumental activity of daily living; 2) anosognosia basic activity of daily living; and 3) anosognosia of depression and disinhibition. AQ-D-K score was significantly correlated with the clinician-rated anosognosia rating scale (ARS), center for epidemiological studies-depression scale (CES-D) and state-trait anxiety inventory (STAI).
Conclusion
The findings suggest that the AQ-D-K is a reliable and valid scale for evaluating anosognosia for AD dementia patients using Korean language.
4.Validation of the Korean Version of the Anosognosia Questionnaire for Dementia
Gi Hwan BYEON ; Woo Jin KIM ; Min Soo BYUN ; Jun Ho LEE ; So Yeon JEON ; Kang KO ; Kiyoung SUNG ; Dongkyun HAN ; Haejung JOUNG ; Younghwa LEE ; Gijung JUNG ; Han Na LEE ; Dahyun YI ; Dong Young LEE ;
Psychiatry Investigation 2021;18(4):324-331
Objective:
Anosognosia is a common phenomenon in individuals with dementia. Anosognosia Questionnaire for dementia (AQ-D) is a well-known scale for evaluating anosognosia. This study aimed to establish a Korean version of the AQ-D (AQ-D-K) and to evaluate the reliability and validity of the AQ-D-K in patients with Alzheimer’s disease (AD) dementia.
Methods:
We translated the original English version of AQ-D into Korean (AQ-D-K). Eighty-four subjects with very mild or mild AD dementia and their caregivers participated. Reliability of AQ-D-K was assessed by internal consistency and one-month test-retest reliability. Construct validity and concurrent validity were also evaluated.
Results:
Internal consistencies of the AQ-D-K patient form and caregiver form were high (Cronbach alpha 0.95 and 0.93, respectively). The test-retest reliability of AQ-D-K measured by intra-class correlation coefficient was 0.84. Three factors were identified: 1) anosognosia of instrumental activity of daily living; 2) anosognosia basic activity of daily living; and 3) anosognosia of depression and disinhibition. AQ-D-K score was significantly correlated with the clinician-rated anosognosia rating scale (ARS), center for epidemiological studies-depression scale (CES-D) and state-trait anxiety inventory (STAI).
Conclusion
The findings suggest that the AQ-D-K is a reliable and valid scale for evaluating anosognosia for AD dementia patients using Korean language.